Fate Therapeutics Inc
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Diego, CA
FATE chart
What traders are saying about $FATE
Latest postsFate Therapeutics Inc news
- Form 13D/A FATE THERAPEUTICS INC For: 9 November By Investing.com
Investing.com Canada ·
- A fund crossed 5% of Fate Therapeutics (FATE) without trading since the prior amendment.
Stock Titan ·
- Fate Therapeutics Inc (F6T.HA) Stock Forum & Discussion - Yahoo Finance
Yahoo! Finance Canada ·
- Form 144 FATE THERAPEUTICS INC For: 7 November By Investing.com
Investing.com Australia ·
- A Quick Look at Today's Ratings for Fate Therapeutics(FATE.US), With a Forecast Between $2.5 to $8
Moomoo ·
- Fate Therapeutics (NASDAQ:FATE) Stock Rating Lowered by Wall Street Zen
MarketBeat ·
- BofA Securities Adjusts Fate Therapeutics Price Target to $2.50 From $2.20
Moomoo ·
- Fate Therapeutics (NASDAQ:FATE) Given New $3.00 Price Target at Wells Fargo & Company
MarketBeat ·
- Wells Fargo maintains Fate Therapeutics at Equal-Weight, lowers price target to $3 from $3.50
TradingView ·
- Fate Therapeutics (NASDAQ:FATE) Share Price Breaks Below 200-Day Moving Average - What's Next?
MarketBeat ·
- Fate Therapeutics Inc (F6T.HA) interactive stock chart
Yahoo Finance UK ·
- Fate Therapeutics Enters $100 Million At-the-Market Sales Agreement
TipRanks ·
Fate Therapeutics Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $6.6M | $13.6M | $63.5M | $96.3M |
| Net income | -$136.3M | -$186.3M | -$160.9M | -$281.7M |
| Diluted EPS | $-1.15 | $-1.64 | $-1.64 | $-2.91 |
| Total assets (year end) | $318.9M | $440.7M | $506.2M | $705.6M |
| Cash and equivalents (year end) | $46.6M | $36.1M | $41.9M | $61.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Fate Therapeutics Inc
- Ticker
- FATE (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Diego, CA
- Fiscal year end
- December 31
- SEC CIK
- 1434316
Frequently asked questions
What exchange is Fate Therapeutics Inc listed on?
Fate Therapeutics Inc trades on the Nasdaq under the ticker symbol FATE.
What industry is Fate Therapeutics Inc in?
Fate Therapeutics Inc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Fate Therapeutics Inc headquartered?
Fate Therapeutics Inc's business address on file with the SEC is in San Diego, CA.
When does Fate Therapeutics Inc's fiscal year end?
Fate Therapeutics Inc's fiscal year ends on December 31.
How much revenue did Fate Therapeutics Inc report?
Fate Therapeutics Inc reported $6.6M in revenue for calendar year 2025, according to its SEC filings.